JUL 30, 2021 7:27 AM PDT

Obesity Reduces Mortality in Advanced Prostate Cancer

WRITTEN BY: Annie Lennon

Obese patients with an advanced form of prostate cancer survive longer than their slimmer counterparts, according to researchers at San Raffaele University in Italy. The study was presented at the 36th Annual European Association of Urology (EAU) Congress

Obesity is generally known as a risk factor for many conditions, including several kinds of cancer. However, some studies have shown that obesity offers a survival advantage in some cancers, in what is known as the 'obesity paradox'. 

For the present study, the researchers recruited 1577 patients with metastatic castration-resistant prostate cancer (mCRPC) for three phase 3 randomized controlled trials. Their average age was 69 years, and their median body mass index (BMI) was 28. The median follow-up for participants was 12 months. 

In the end, the researchers found that 30% of obese patients (BMI >30) survived the 36-month follow-up. The same was true for just 20% of those who were overweight (25<BMI<30) and of normal weight (20< BMI <25). 

The researchers say that this is another example of the obesity paradox. Its underlying mechanisms, however, are unknown. One suggestion, they say, is that as older obese patients tend to take medications for other conditions, their enhanced survival rate may be due to some unknown interactions. 

Meanwhile, Peter Albers, Peter Albers who chairs the EAU Scientific Congress, suggested that patients with a higher BMI may tolerate treatment toxicity and side effects better than those with lower BMI's. He added that hormones found in tissue fat may have a protective effect and that healthy men with slightly higher BMI's are known to have a higher overall life expectancy compared to those who are very slim. 

Until further research is conducted, however, these explanations remain hypotheses. Therefore, the researchers do not recommend weight gain for people with this disease. 

 

Sources: 36th Annual European Association of Urology CongressEurekAlert

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 20, 2021
Clinical & Molecular DX
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
MAY 20, 2021
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
A UK-based research study has shown that while ovarian cancer screening is beneficial for detecting cancers earlier, it ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
MAY 29, 2021
Cancer
New device detects skin cancer from tensile stiffness
MAY 29, 2021
New device detects skin cancer from tensile stiffness
A research team composed of scientists from City University of Hong Kong (CityU) has designed an automated non-invasive ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
Loading Comments...